All true, but the trade-offs here are clear. This drug is being looked at for patients who are in the hospital on oxygen or a ventilator. At that point side eff

All true, but the trade-offs here are clear. This drug is being looked at for patients who are in the hospital on oxygen or a ventilator. At that point side effects aren't very relevant since their odds of dying are somewhere between 25-40%. Anything that significantly reduces those odds is going to be worth it.